POLY MEDICURE LIMITED (POLYMED) financials

POLY MEDICURE LIMITED (POLYMED) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Market Cap: ₹14,901Cr.
Current Price: ₹1,470
Stock P/E: 43.7
ROE: 9.62%
ROCE: 13.4%
Book Value: ₹301
Dividend Yield: 0.24%
52W High / Low: ₹2,094/1,182

In Jun 2026, POLY MEDICURE LIMITED (POLYMED) reported sales ₹431 Cr and net profit ₹88 Cr.

Annual TTM: sales ₹1,710 Cr, net profit ₹336 Cr.

Shareholding: Promoters 62.41% (Sep 2026), FIIs 5.36% (Sep 2026), DIIs 15.90% (Sep 2026), Public 16.33% (Sep 2026), No. of Shareholders 74,153% (Sep 2026).

POLYMED quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	402	411	421	384	417	419	443	431
Expenses	290	295	305	283	305	307	322	310
Operating Profit	113	115	116	101	111	112	121	121
OPM %	28%	28%	28%	26%	27%	27%	27%	28%
Other Income	27	22	24	42	34	23	15	29
Interest	3	3	2	3	3	4	4	4
Depreciation	20	21	21	23	24	25	26	26
Profit before tax	117	113	116	117	118	106	107	119
Tax %	25%	25%	26%	25%	25%	26%	25%	26%
Net Profit	87	85	87	88	89	78	81	88
EPS in Rs	8.61	8.40	8.55	8.68	8.79	7.73	7.95	8.69
Raw PDF	—	—	—	—	—	—	—	—

POLYMED profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	646	746	879	1,068	1,306	1,601	1,662	1,710
Expenses	483	536	665	801	954	1,153	1,213	1,244
Operating Profit	162	210	214	266	352	448	449	465
OPM %	25%	28%	24%	25%	27%	28%	27%	27%
Other Income	19	19	39	36	57	89	113	100
Interest	20	10	5	10	13	14	16	15
Depreciation	39	46	53	56	62	81	98	101
Profit before tax	122	173	195	237	335	443	448	449
Tax %	24%	25%	25%	24%	25%	25%	25%	—
Net Profit	92	130	146	179	252	331	336	336
EPS in Rs	10.47	13.51	15.23	18.66	26.23	32.70	33.15	33.16
Dividend Payout %	19%	19%	16%	16%	11%	11%	11%	—

POLYMED balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	44	44	48	48	48	48	51	51
Reserves	336	385	906	1,029	1,186	1,410	2,694	3,002
Borrowings	150	194	126	111	137	164	172	252
Other Liabilities	103	117	107	146	167	199	224	246
Total Liabilities	633	740	1,187	1,334	1,538	1,821	3,140	3,550
Fixed Assets	272	328	389	451	598	831	1,047	1,217
CWIP	19	25	21	43	78	71	93	96
Investments	42	58	385	384	181	221	1,126	1,243
Other Assets	300	330	392	456	681	699	874	994
Total Assets	633	740	1,187	1,334	1,538	1,821	3,140	3,550

POLYMED cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	113	127	116	126	197	256	230	245
Cash from Investing Activity	-104	-106	-434	-89	-189	-237	-1,184	-268
Cash from Financing Activity	-10	-22	319	-40	-8	-17	953	28
Net Cash Flow	-1	-1	1	-2	-0	2	-2	5
Free Cash Flow	68	23	23	-24	-40	-13	-94	-49
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	105%	100%	76%	81%	96%	94%	71%	76%

POLYMED shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	62.44%	62.44%	62.44%	62.42%	62.42%	62.42%	62.42%	62.41%
FIIs	12.33%	11.46%	11.41%	9.77%	9.41%	5.92%	5.56%	5.36%
DIIs	11.66%	11.96%	11.72%	13.53%	13.84%	15.60%	16.08%	15.90%
Public	13.57%	14.13%	14.43%	14.28%	14.34%	16.08%	15.94%	16.33%
No. of Shareholders	60,686	65,583	71,142	64,400	67,750	73,414	73,643	74,153

POLYMED key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	77	68	73	80	76	72	78	97
Inventory Days	138	241	202	210	222	194	215	242
Days Payable	93	144	104	109	95	89	66	73
Cash Conversion Cycle	123	165	171	181	203	177	227	267
Working Capital Days	58	45	73	80	65	52	74	96
ROCE %	23%	25%	21%	16%	19%	22%	18%	13%

POLYMEDUpdated 22 Oct 2026, 5:56

Poly Medicure Limited

POLYMEDUpdated 22 Oct 2026, 5:56

Market Cap

₹14,901Cr.

Current Price

₹1,470

High / Low

₹2,094/1,182

Stock P/E

43.7

ROE9.62%

ROCE13.4%

Book Value₹301

Face Value₹5.00

Dividend Yield0.24%

About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	306	2	220	13	15	81	25	61	6.31
Sep 2023	320	2	237	13	15	78	24	59	6.17
Dec 2023	321	3	236	17	16	82	25	61	6.41
Mar 2024	361	3	264	16	16	94	25	71	7.35
Jun 2024	367	3	266	17	19	96	25	72	7.53
Sep 2024	402	3	290	27	20	117	25	87	8.61
Dec 2024	411	3	295	22	21	113	25	85	8.4
Mar 2025	421	2	305	24	21	116	26	87	8.55
Jun 2025	384	3	283	42	23	117	25	88	8.68
Sep 2025	417	3	305	34	24	118	25	89	8.79
Dec 2025	419	4	307	23	25	106	26	78	7.73
Mar 2026	443	4	322	15	26	107	25	81	7.95
Jun 2026	431	4	310	29	26	119	26	88	8.69

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	373	10	288	28	18	84	27	61	6.92
Mar 2016	393	10	307	8	20	65	27	47	5.36
Mar 2017	439	8	345	13	23	76	26	56	6.37
Mar 2018	507	11	386	14	28	96	27	70	7.96
Mar 2019	586	13	452	16	36	100	34	66	7.51
Mar 2020	646	20	483	19	39	122	24	92	10.47
Mar 2021	746	10	536	19	46	173	25	130	13.51
Mar 2022	879	5	665	39	53	195	25	146	15.23
Mar 2023	1068	10	801	36	56	237	24	179	18.66
Mar 2024	1306	13	954	57	62	335	25	252	26.23
Mar 2025	1601	14	1153	89	81	443	25	331	32.7
Mar 2026	1662	16	1213	113	98	448	25	336	33.15
TTM	1710	15	1244	100	101	449	—	336	33.16

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	62.41%
FIIs	5.36%
DIIs	15.9%
Public	16.33%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	53.17%	14.1%	5.46%	27.28%
Mar 2024	53.14%	12.37%	7.21%	27.25%
Jun 2024	66.02%	9.91%	9.34%	14.72%
Sep 2024	62.56%	11.88%	12.33%	13.23%
Dec 2024	62.44%	12.33%	11.66%	13.57%
Mar 2025	62.44%	11.46%	11.96%	14.13%
Jun 2025	62.44%	11.41%	11.72%	14.43%
Sep 2025	62.42%	9.77%	13.53%	14.28%
Dec 2025	62.42%	9.41%	13.84%	14.34%
Mar 2026	62.42%	5.92%	15.6%	16.08%
Jun 2026	62.42%	5.56%	16.08%	15.94%
Sep 2026	62.41%	5.36%	15.9%	16.33%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	22	170	76	87	354	161	10	6	178	354
Mar 2016	22	202	79	73	376	177	14	6	180	376
Mar 2017	44	225	97	83	449	201	20	6	222	449
Mar 2018	44	290	127	93	555	260	18	18	258	555
Mar 2019	44	336	150	103	633	272	19	42	300	633
Mar 2020	44	385	194	117	740	328	25	58	330	740
Mar 2021	48	906	126	107	1187	389	21	385	392	1187
Mar 2022	48	1029	111	146	1334	451	43	384	456	1334
Mar 2023	48	1186	137	167	1538	598	78	181	681	1538
Mar 2024	48	1410	164	199	1821	831	71	221	699	1821
Mar 2025	51	2694	172	224	3140	1047	93	1126	874	3140
Mar 2026	51	3002	252	246	3550	1217	96	1243	994	3550

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	63	-57	-9	-2
Mar 2016	62	-30	-31	1
Mar 2017	55	-54	-1	0
Mar 2018	76	-87	14	3
Mar 2019	113	-104	-10	-1
Mar 2020	127	-106	-22	-1
Mar 2021	116	-434	319	1
Mar 2022	126	-89	-40	-2
Mar 2023	197	-189	-8	0
Mar 2024	256	-237	-17	2
Mar 2025	230	-1184	953	-2
Mar 2026	245	-268	28	5

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	58	75	79	81	77	68	73	80	76	72	78	97
Inventory Days	146	105	193	207	138	241	202	210	222	194	215	242
Days Payable	103	77	136	130	93	144	104	109	95	89	66	73
Cash Conversion Cycle	101	103	136	157	123	165	171	181	203	177	227	267
Working Capital Days	24	36	58	74	58	45	73	80	65	52	74	96
ROCE %	30%	26%	25%	26%	23%	25%	21%	16%	19%	22%	18%	13%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of POLY MEDICURE LIMITED (POLYMED)?

The reported market capitalisation for POLY MEDICURE LIMITED (POLYMED) is ₹14,901Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of POLYMED?

The current price shown for POLY MEDICURE LIMITED (POLYMED) on Fincrux is ₹1,470 with a 52-week high/low of ₹2,094/1,182.

What is the P/E ratio of POLY MEDICURE LIMITED (POLYMED)?

The stock P/E for POLY MEDICURE LIMITED (POLYMED) is 43.7 on Fincrux, with ROE at 9.62% and ROCE at 13.4%.

What were POLYMED latest quarterly results?

For Jun 2026, POLY MEDICURE LIMITED (POLYMED) reported sales ₹431 Cr and net profit ₹88 Cr (figures in ₹ crore unless noted).

What are POLYMED annual sales and net profit?

For TTM, POLY MEDICURE LIMITED (POLYMED) shows sales of ₹1,710 Cr and net profit of ₹336 Cr on the Fincrux profit & loss statement.

Who owns POLY MEDICURE LIMITED (POLYMED)?

Latest shareholding for POLY MEDICURE LIMITED (POLYMED) on Fincrux: Promoters 62.41% (Sep 2026), FIIs 5.36% (Sep 2026), DIIs 15.90% (Sep 2026), Public 16.33% (Sep 2026), No. of Shareholders 74,153% (Sep 2026).

Where can I find POLY MEDICURE LIMITED (POLYMED) financials?

POLY MEDICURE LIMITED (POLYMED) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show POLYMED balance sheet and cash flow?

Yes. The POLY MEDICURE LIMITED (POLYMED) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 22 October 2026 at 5:56